Lecture

Understanding SARS-CoV-2 Structure & Antiviral Strategies

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Description

This lecture delves into the structure of SARS-CoV-2, exploring key proteins and their functions in viral replication. It discusses potential antiviral strategies, such as main protease inhibitors and virucidal materials, highlighting their efficacy in inhibiting viral attachment and replication. The presentation covers in vitro and ex vivo studies, showcasing the effectiveness of various compounds in combating viral infections. Insights from cryo-TEM studies and in vivo experiments provide a comprehensive understanding of the mechanisms behind antiviral activity. The lecture also touches upon the classification of viruses based on attachment ligands and the importance of cyclodextrins in antiviral therapy.

Official source

Ontological neighbourhood

Health sciences

Infectious diseases: Viral disease

Related concepts (32)

Antiviral drug

Antiviral drugs are a class of medication used for treating viral infections. Most antivirals target specific viruses, while a broad-spectrum antiviral is effective against a wide range of viruses. Antiviral drugs are one class of antimicrobials, a larger group which also includes antibiotic (also termed antibacterial), antifungal and antiparasitic drugs, or antiviral drugs based on monoclonal antibodies. Most antivirals are considered relatively harmless to the host, and therefore can be used to treat infections.

Virus

A virus is a submicroscopic infectious agent that replicates only inside the living cells of an organism. Viruses infect all life forms, from animals and plants to microorganisms, including bacteria and archaea. Since Dmitri Ivanovsky's 1892 article describing a non-bacterial pathogen infecting tobacco plants and the discovery of the tobacco mosaic virus by Martinus Beijerinck in 1898, more than 11,000 of the millions of virus species have been described in detail.

Viral envelope

A viral envelope is the outermost layer of many types of viruses. It protects the genetic material in their life cycle when traveling between host cells. Not all viruses have envelopes. A viral envelope protein or E protein is a protein in the envelope, which may be acquired by the capsid from an infected host cell. Numerous human pathogenic viruses in circulation are encased in lipid bilayers, and they infect their target cells by causing the viral envelope and cell membrane to fuse.

Viral entry

Viral entry is the earliest stage of infection in the viral life cycle, as the virus comes into contact with the host cell and introduces viral material into the cell. The major steps involved in viral entry are shown below. Despite the variation among viruses, there are several shared generalities concerning viral entry. How a virus enters a cell is different depending on the type of virus it is. A virus with a nonenveloped capsid enters the cell by attaching to the attachment factor located on a host cell.

SARS-CoV-2

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a strain of coronavirus that causes COVID-19, the respiratory illness responsible for the COVID-19 pandemic. The virus previously had the provisional name 2019 novel coronavirus (2019-nCoV), and has also been called human coronavirus 2019 (HCoV-19 or hCoV-19). First identified in the city of Wuhan, Hubei, China, the World Health Organization designated the outbreak a public health emergency of international concern from January 30, 2020, to May 5, 2023.

Related lectures (47)

Viral Taxonomy: RNA Viruses

Covers the taxonomy of RNA viruses, entry routes, influenza virus replication, and paramyxovirus pathogenesis.

Supramolecular Approaches to Design Novel Antivirals

Explores the design of novel antivirals using supramolecular nanostructures and innovative strategies against various viruses.

Untitled

Viral Infection Dynamics

Explores viral infection dynamics, including acute, latent, and persistent infections with examples like Rhinovirus and Herpes Simplex.